Epigral Limited has announced its un-audited financial results for the second quarter and half-year period ending September 30, 2025. The results were disclosed on December 11, 2025, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements). The report was published in the Financial Express in both its English and Gujarati editions, ensuring broad accessibility to investors and stakeholders.

In the correspondence addressed to the National Stock Exchange of India and BSE Limited, Gaurang Trivedi, the Company Secretary & Compliance Officer, expressed gratitude and requested the exchanges to take the results on record. The company's scrip is listed under the symbol EPIGRAL on the NSE and under the code 543332 on the BSE. This announcement marks an important milestone for Epigral as it continues to inform the market about its financial performance amid evolving market conditions.